Citrix Systems Inc. Stock Rises Wednesday, Outperforms Market

Enzolytics Inc

Change company Symbol lookup

Select an option...

ENZC Enzolytics Inc

GREE Greenidge Generation Holdings Inc

MLM Martin Marietta Materials Inc

ERESW East Resources Acquisition Equity Warrant Exp 1st July 2027 *W EXP 07/01/2027

NRAC Noble Rock Acquisition Corp

DCGO DocGo Inc

VELOW Velocity Acquisition Equity Warrant Exp 24 Feb 2028 *W EXP 02/24/2028

MRC MRC Global Inc

BAC Bank of America Corp

BKR Baker Hughes Co

Company profile

Enzolytics, Inc. is a drug development biotechnology company. The Company is engaged in the commercialization of its proteins for the treatment of debilitating infectious diseases. The Company is focused in developing monoclonal antibody therapy and treating infectious diseases. It has anti-HIV therapeutics and a methodology for producing fully human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. The Company has clinically tested anti-HIV therapeutics. The Company has developed a cell line that produces fully human monoclonal antibodies that target and neutralizes the HIV virus. The Company has also created human cell lines that produce human antibodies against other infectious diseases, including rabies, influenza, tetanus, and diphtheria. The Company is testing these antibodies to prepare them for use as therapies against these diseases.

Citrix Systems Inc. Stock Rises Wednesday, Outperforms Market

4:47 pm ET January 19, 2022 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Citrix Systems Inc. (CTXS) rose 3.66% to $104.70 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.97% to 4,532.76 and Dow Jones Industrial Average falling 0.96% to 35,028.65. This was the stock's third consecutive day of gains. Citrix Systems Inc. closed $40.49 below its 52-week high ($145.19), which the company reached on January 27th.

The stock outperformed some of its competitors Wednesday, as Microsoft Corp. (MSFT) rose 0.22% to $303.33, Adobe Inc. (ADBE) rose 0.63% to $516.58, and Oracle Corp. (ORCL) fell 2.54% to $83.38. Trading volume (2.7 M) eclipsed its 50-day average volume of 1.8 M.

Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 19, 2022.

-MarketWatch Automation

(END) Dow Jones Newswires

January 19, 2022 16:47 ET (21:47 GMT)